Denosumab
5 NDCs across 2 manufacturers|0 Generic,5 Brand
Denosumab is used to treat postmenopausal osteoporosis and osteoporotic fractures, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $828 million on Denosumab across 469,000 claims for 288,000 beneficiaries.
Denosumab is available as 5 NDCs from 2 manufacturers (0 generic, 5 brand), with NADAC prices from $1536.91 to $2001.52 per ML — a 30% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
2
competing in market
Price Spread
$1536.91 – $2001.52
per ML
7d Activity
avg -0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amgen Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
RANK Ligand Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing DENOSUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
XGEVA 120 MG/1.7 ML VIAL | $2001.5168 per ML | — |
XGEVA 120 MG/1.7 ML VIAL | $2001.5168 per ML | — |
PROLIA 60 MG/ML SYRINGE | $1862.7440 per ML | -0.05% |
PROLIA 60 MG/ML SYRINGE | $1862.7440 per ML | -0.05% |
JUBBONTI 60 MG/ML SYRINGE | $1536.9051 per ML | -0.02% |
Frequently Asked Questions
What is Denosumab used to treat?
Denosumab is used to treat postmenopausal osteoporosis and osteoporotic fractures, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Denosumab?
In 2024, Medicare Part D spent $828 million on Denosumab across 469,000 claims for 288,000 beneficiaries.
How many Denosumab products are on the market?
The Denosumab drug market contains 5 NDCs from 2 manufacturers — 0 generic and 5 brand products.
What is the price range for Denosumab?
NADAC reference prices for Denosumab range from $1536.9051 to $2001.5168 per ML — a 30% difference between cheapest and most expensive.
Which manufacturers make Denosumab?
2 manufacturers list Denosumab in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (4), Sandoz Inc. (1).
How has the price of Denosumab changed recently?
Over the past 7 days, 0 Denosumab NDCs rose and 3 fell, with a market-wide average change of -0.0%.